Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,totalCurrentAssets,netReceivables,accountsPayable,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,postMarketPrice,postMarketChange,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,postMarketChangePercent,postMarketTime,epsTrailingTwelveMonths,epsForward,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,industry,address2
t0,FWP,78644000,7018890,46000,,-2095000,,-2095000,635500,0,-681500,-681500,,-46500,,,,0,0,681500,0,-1413500,,-2095000,-2095000,1070000,78644000,79714000,154000,-14825000,93315000,3000,79087000,1070000,93315000,79711000,287000,476000,0,78641000,en-US,US,EQUITY,True,Delayed Quote,USD,8.8,0.10000038,-8.130944,8.7 - 9.67,9.47,8.72,9.0,8,8,finmb_29481881,NasdaqCM,USD,383431,191616,2.8989997,0.49974135,5.801 - 20.31,-11.61,-0.5716396,5.801,20.31,1575590400,1618430400,1632135540,1632571200,1.1494297,1630529421,-0.98,-0.09,-14400000,11.411,10.117222,-1.417222,-0.14008015,8.132855,0.5671444,2,Forward Pharma A/S,Forward Pharma A/S,8.7,1630526403,-0.77000046,9.49,9.67,8.7,343073,POST,NCM,us_market,0.06973497,61064340,-96.666664,0.7624222,15,America/New_York,EDT,False,False,0,1.65,,,20.31,5.8,10.12,8.13,383.43k,191.62k,7.02M,,1.39M,0.00%,14.03%,5.25k,0.11,,0.07%,2.45k,,,,,,0.00%,"Dec 05, 2019","Sep 11, 2017",1:7,"Dec 05, 2019","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-2.68%,-8.26%,,,,,-3.38M,-6.45M,-0.98,,79.09M,11.48,,,74.50,11.41,-5.71M,-1.43M,Value,1100,Healthcare,4,"Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.",Copenhagen,45 33 44 42 42,Denmark,http://www.forward-pharma.com,86400,Ãstergade 24A,Biotechnology,1st Floor Copenhagen K
t-1,FWP,78644000,7018890,46000,,-2095000,,-2095000,635500,0,-681500,-681500,,-46500,,,,0,0,681500,0,-1413500,,-2095000,-2095000,1070000,78644000,79714000,154000,-14825000,93315000,3000,79087000,1070000,93315000,79711000,287000,476000,0,78641000,en-US,US,EQUITY,True,Delayed Quote,USD,8.8,0.10000038,-8.130944,8.7 - 9.67,9.47,8.72,9.0,8,8,finmb_29481881,NasdaqCM,USD,383431,191616,2.8989997,0.49974135,5.801 - 20.31,-11.61,-0.5716396,5.801,20.31,1575590400,1618430400,1632135540,1632571200,1.1494297,1630529421,-0.98,-0.09,-14400000,11.411,10.117222,-1.417222,-0.14008015,8.132855,0.5671444,2,Forward Pharma A/S,Forward Pharma A/S,8.7,1630526403,-0.77000046,9.49,9.67,8.7,343073,POST,NCM,us_market,0.06973497,61064340,-96.666664,0.7624222,15,America/New_York,EDT,False,False,0,1.65,,,20.31,5.8,10.12,8.13,383.43k,191.62k,7.02M,,1.39M,0.00%,14.03%,5.25k,0.11,,0.07%,2.45k,,,,,,0.00%,"Dec 05, 2019","Sep 11, 2017",1:7,"Dec 05, 2019","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-2.68%,-8.26%,,,,,-3.38M,-6.45M,-0.98,,79.09M,11.48,,,74.50,11.41,-5.71M,-1.43M,Value,1100,Healthcare,4,"Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.",Copenhagen,45 33 44 42 42,Denmark,http://www.forward-pharma.com,86400,Ãstergade 24A,Biotechnology,1st Floor Copenhagen K
t-2,FWP,75481000,7018890,117500,,-1129500,,-1129500,894000,0,-1011500,-1011500,,-46500,,,,0,0,1011500,0,-118000,,-1129500,-1129500,642000,75481000,76123000,154000,-10738000,86065000,3000,75626000,642000,86065000,76120000,366000,165000,0,75478000,en-US,US,EQUITY,True,Delayed Quote,USD,8.8,0.10000038,-8.130944,8.7 - 9.67,9.47,8.72,9.0,8,8,finmb_29481881,NasdaqCM,USD,383431,191616,2.8989997,0.49974135,5.801 - 20.31,-11.61,-0.5716396,5.801,20.31,1575590400,1618430400,1632135540,1632571200,1.1494297,1630529421,-0.98,-0.09,-14400000,11.411,10.117222,-1.417222,-0.14008015,8.132855,0.5671444,2,Forward Pharma A/S,Forward Pharma A/S,8.7,1630526403,-0.77000046,9.49,9.67,8.7,343073,POST,NCM,us_market,0.06973497,61064340,-96.666664,0.7624222,15,America/New_York,EDT,False,False,0,1.65,,,20.31,5.8,10.12,8.13,383.43k,191.62k,7.02M,,1.39M,0.00%,14.03%,5.25k,0.11,,0.07%,2.45k,,,,,,0.00%,"Dec 05, 2019","Sep 11, 2017",1:7,"Dec 05, 2019","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-2.68%,-8.26%,,,,,-3.38M,-6.45M,-0.98,,79.09M,11.48,,,74.50,11.41,-5.71M,-1.43M,Value,1100,Healthcare,4,"Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.",Copenhagen,45 33 44 42 42,Denmark,http://www.forward-pharma.com,86400,Ãstergade 24A,Biotechnology,1st Floor Copenhagen K
t-3,FWP,75481000,7018890,117500,,-1129500,,-1129500,894000,0,-1011500,-1011500,,-46500,,,,0,0,1011500,0,-118000,,-1129500,-1129500,642000,75481000,76123000,154000,-10738000,86065000,3000,75626000,642000,86065000,76120000,366000,165000,0,75478000,en-US,US,EQUITY,True,Delayed Quote,USD,8.8,0.10000038,-8.130944,8.7 - 9.67,9.47,8.72,9.0,8,8,finmb_29481881,NasdaqCM,USD,383431,191616,2.8989997,0.49974135,5.801 - 20.31,-11.61,-0.5716396,5.801,20.31,1575590400,1618430400,1632135540,1632571200,1.1494297,1630529421,-0.98,-0.09,-14400000,11.411,10.117222,-1.417222,-0.14008015,8.132855,0.5671444,2,Forward Pharma A/S,Forward Pharma A/S,8.7,1630526403,-0.77000046,9.49,9.67,8.7,343073,POST,NCM,us_market,0.06973497,61064340,-96.666664,0.7624222,15,America/New_York,EDT,False,False,0,1.65,,,20.31,5.8,10.12,8.13,383.43k,191.62k,7.02M,,1.39M,0.00%,14.03%,5.25k,0.11,,0.07%,2.45k,,,,,,0.00%,"Dec 05, 2019","Sep 11, 2017",1:7,"Dec 05, 2019","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-2.68%,-8.26%,,,,,-3.38M,-6.45M,-0.98,,79.09M,11.48,,,74.50,11.41,-5.71M,-1.43M,Value,1100,Healthcare,4,"Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.",Copenhagen,45 33 44 42 42,Denmark,http://www.forward-pharma.com,86400,Ãstergade 24A,Biotechnology,1st Floor Copenhagen K
